Subsidiary of Lupin signs agreement with Creso
Subsidiary of Lupin signs agreement with Creso

Subsidiary of Lupin signs agreement with Creso

Apurva Joshi Article rating: 3.0

Lupin Limited announced that its subsidiary in South Africa ‘Pharma Dynamics’ has signed a Commercial Agreement with Creso Pharma (Creso) for the hemp oil based cannaQIX. Creso has bestowed Pharma Dynamics with sole distribution rights of its organic, broad spectrum hemp oil nutraceutical, cannaQIX 10, across South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda.

Sensex skyrockets up by 792 points
Sensex skyrockets up by 792 points

Sensex skyrockets up by 792 points

DSIJ Intelligence Article rating: 5.0

Registering a stupendous 2 per cent gain, the benchmark indices recovered as the central government announced the rollback of FPIs surcharge, a fiscal package for state-owned banks and stimulus for auto sector to revive the economy on Friday.

BHEL secures orders worth Rs. 2500 crore from NTPC
BHEL secures orders worth Rs. 2500 crore from NTPC

BHEL secures orders worth Rs. 2500 crore from NTPC

Apurva Joshi Article rating: 4.3

Bharat Heavy Electricals Limited (BHEL) has bagged two orders for emission control equipment at its thermal power plants. The orders that are worth Rs. 2500 crore, were placed by public sector power company - NTPC Limited.

BL Kashyap secures Rs. 460.53 crore orders
BL Kashyap secures Rs. 460.53 crore orders

BL Kashyap secures Rs. 460.53 crore orders

DSIJ Intelligence Article rating: 3.9

Civil engineering construction company B.L. Kashyap and Sons Limited received orders in Bengaluru and Trivandrum. Following the announcement, the stock was locked in its upper circuit in post lunch session on Monday.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

DSIJ Intelligence Article rating: 5.0

The markets on August 26, 2019 opened gap up. BSE Sensex is trading at 37,409.81, up by 708.65 points and the Nifty is trading at 11,029.00, up by 199.65 points.

USFDA makes three Form 483 observations for Ipca Lab
USFDA makes three Form 483 observations for Ipca Lab

USFDA makes three Form 483 observations for Ipca Lab

Apurva Joshi Article rating: 3.5

USFDA had conducted the inspection of Ipca Laboratories’ formulations manufacturing unit situated at Piparia (Silvassa) from August 19-23, 2019. At the conclusion of the inspection, the USFDA issued a Form 483 with 3 observations.

RSS
First32003201320232033205320732083209Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR